TickerFacts.

Stemtech Corp (STEK): Revenue

Annual figures by period end, from SEC filings.

$2.88M
Year ended 2025-12-31
$2.40M
Trailing 12 months to 2026-06-30
-14.2%
3-year compound annual growth
-8.1%
5-year compound annual growth
$5.05M2020-12-31: $4.38M2021-12-31: $4.32M2022-12-31: $4.56M2023-12-31: $4.92M2024-12-31: $5.05M2025-12-31: $2.88M$2.88M
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$2.88M-43.1%2026-05-29, From 2025-01-01
2024-12-31$5.05M+2.7%2026-05-29, From 2024-01-01
2023-12-31$4.92M+7.9%2025-06-30, From 2023-01-01
2022-12-31$4.56M+5.5%2024-07-10, From 2022-01-01
2021-12-31$4.32M-1.4%2023-04-17, From 2021-01-01
2020-12-31$4.38Mn/a2022-04-01, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Stemtech Corp (STEK)2025-12-31$2.88M-43.1%
HWH International Inc. (ESYN)2025-12-31$866.9K-30.8%
DataMeds AI, Inc. (MEDS)2025-12-31$23.34M+28.7%
Cosmos Health Inc. (COSM)2025-12-31$65.27M+19.9%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$1.49B-14.3%
Herbalife Ltd. (HLF)2025-12-31$5.04B+0.9%
Cardinal Health Inc (CAH)2026-06-30$254.25B+14.2%
Cencora, Inc. (COR)2025-09-30$321.33B+9.3%
McKesson Corp (MCK)2026-03-31$403.43B+12.4%

Compare STEK, ESYN, MEDS, COSM side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗